Stem Holdings, Inc. Begins Trading on the Canadian Securities Exchange Under Ticker Symbol “STEM”
July 16 2018 - 10:48AM
Stem Holdings, Inc. (“
Stem” or the
“
Company”) (OTCQB:STMH) (CSE:STEM) is pleased to
announce that its common shares have begun trading under the ticker
symbol “STEM” on the Canadian Securities Exchange (the
“
CSE”).
Stem is an innovative real estate company,
which acquires and improves properties for the cannabis industry.
Stem owns multiple licensed cultivation facilities and retail
stores in Oregon and Nevada. The Company has also developed
partnerships with a number of award-winning cannabis
brands.
“Listing on the CSE provides Stem access to
capital to fund the Company’s strategy for growth and leverage our
position as a leader in the cannabis industry,” said Stem’s CEO,
Adam Berk. “We are excited to provide an opportunity for global
investors to participate in our expansion strategy that focuses on
multiple sectors of the market, while still providing value to our
current shareholders.”
A listing statement with information about Stem
and prepared in accordance with the policies of the CSE will be
available on SEDAR at www.sedar.com.
About Stem Holdings, Inc.
Stem has positioned itself as a leader in the
U.S. cannabis industry by building state-of-the-art licensed
solutions, including: cultivation, processing and retail properties
across multiple U.S. markets. As an innovative real estate company,
Stem acquires and improves properties for the cannabis industry.
Stem has set itself apart by building and partnering with a variety
of marijuana-based businesses, from edibles to hemp cultivation.
The Company has developed an extensive portfolio of award-winning
consumer-facing brands, partnering with well known, branded
cannabis operators with a proven track record of success, such as
TJ’s Gardens, Cannavore, incredibles, Doseology and Green T-Farms.
For more information, visit www.stemholdings.com.
Cautionary Note Regarding
Forward-Looking Information
This press release contains statements which
constitute “forward-looking information” within the meaning of
applicable securities laws, including statements regarding the
plans, intentions, beliefs and current expectations of the
management of Stem with respect to future business activities.
Forward-looking information is often identified by the words “may”,
“would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”,
“believe”, “estimate”, “expect” or similar expressions and include
information regarding: (i) the ability of the Company to
successfully achieve its business objectives, (ii) plans for
expansion of Stem, and (iii) expectations for other economic,
business, and/or competitive factors.
Investors are cautioned that forward-looking
information is not based on historical facts but instead reflect
the management of Stem’s expectations, estimates or projections
concerning future results or events based on the opinions,
assumptions and estimates of management considered reasonable at
the date the statements are made. Although Stem believes that the
expectations reflected in such forward-looking information are
reasonable, such information involves risks and uncertainties, and
undue reliance should not be placed on such information, as unknown
or unpredictable factors could have material adverse effects on
future results, performance or achievements of the Company. Among
the key factors that could cause actual results to differ
materially from those projected in the forward-looking information
are the following: changes in general economic, business and
political conditions, including changes in the financial markets;
and in particular in the ability of the Company to raise debt and
equity capital in the amounts and at the costs that it expects;
adverse changes in the public perception of cannabis; decreases in
the prevailing prices for cannabis and cannabis products in the
markets that the Company operates in; adverse changes in applicable
laws; or adverse changes in the application or enforcement of
current laws, including those related to taxation; the inability to
locate and acquire suitable companies, properties and assets
necessary to execute on the Company’s business plans; and
increasing costs of compliance with extensive government
regulation. This forward-looking information may be affected by
risks and uncertainties in the business of Stem and market
conditions.
Should one or more of these risks or
uncertainties materialize, or should assumptions underlying the
forward-looking information prove incorrect, actual results may
vary materially from those described herein as intended, planned,
anticipated, believed, estimated or expected. Although Stem has
attempted to identify important risks, uncertainties and factors
which could cause actual results to differ materially, there may be
others that cause results not to be as anticipated, estimated or
intended. Stem does not intend, and does not assume any obligation,
to update this forward-looking information except as otherwise
required by applicable law.
No securities regulatory authority has in any
way passed upon the merits of the proposed transactions described
in this news release or has approved or disapproved of the contents
of this news release.
For further information, please contact:
Investor Relations Contact:
Amato and Partners, LLC
Investor Relations Counsel
212.460.0360
admin@amatopartners.com
Media Contact:
Mauria Betts
Director of Branding and Public Relations
(971) 266-1908
mauria@stemholdings.com
Microbot Medical (NASDAQ:MBOT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Microbot Medical (NASDAQ:MBOT)
Historical Stock Chart
From Apr 2023 to Apr 2024